Adamas Pharma (ADMS) Tops Q2 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. PLTR
4. LITE
5. REGN
6. MRVL
7. ABBV
8. CHKP
9. MAR
10. CL

Go back to Adamas Pharma (ADMS) Tops Q2 EPS by 2c

Adamas Reports Second Quarter 2021 Financial Results

August 9, 2021 4:01 PM EDT

Second quarter 2021 total revenues of $22.0 million, a 17% increase over second quarter 2020

GOCOVRI new paid prescriptions of 730, a 97% increase over second quarter 2020

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today reported financial results for the second quarter ended June 30, 2021, and recent corporate highlights.

We delivered a strong performance in the second quarter, with a robust increase in demand set to fuel future... More